Dr Reddys Laboratories Stock Buy Hold or Sell Recommendation
| RDY Stock | USD 71.49 0.66 0.91% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Dr Reddys Laboratories is 'Strong Buy'. Macroaxis provides Dr Reddys buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RDY positions. The advice algorithm takes into account all of Dr Reddys' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Dr Reddys' buy or sell advice are summarized below:
Real Value 78.02 | Target Price 70.11 | Hype Value 72.17 | Market Value 71.49 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Dr Reddys Laboratories given historical horizon and risk tolerance towards Dr Reddys. When Macroaxis issues a 'buy' or 'sell' recommendation for Dr Reddys Laboratories, the advice is generated through an automated system that utilizes algorithms and statistical models.
RDY |
Execute Dr Reddys Buy or Sell Advice
The RDY recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Dr Reddys Laboratories. Macroaxis does not own or have any residual interests in Dr Reddys Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Dr Reddys' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Hold | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Dr Reddys Trading Alerts and Improvement Suggestions
| Latest headline from zacks.com: Zacks Industry Outlook Highlights Teva, Dr. Reddys and Viatris |
Dr Reddys Returns Distribution Density
The distribution of Dr Reddys' historical returns is an attempt to chart the uncertainty of Dr Reddys' future price movements. The chart of the probability distribution of Dr Reddys daily returns describes the distribution of returns around its average expected value. We use Dr Reddys Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Dr Reddys returns is essential to provide solid investment advice for Dr Reddys.
| Mean Return | 0.09 | Value At Risk | -1.73 | Potential Upside | 1.66 | Standard Deviation | 1.14 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Dr Reddys historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
RDY Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Dr Reddys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dr Reddys Laboratories backward and forwards among themselves. Dr Reddys' institutional investor refers to the entity that pools money to purchase Dr Reddys' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bank Of America Corp | 2023-12-31 | 562.6 K | Gqg Partners Llc | 2023-12-31 | 437 K | Lazard Asset Management Llc | 2023-12-31 | 347.1 K | Grantham, Mayo, Van Otterloo & Co., Llc | 2023-12-31 | 329.1 K | Schroder Investment Management Group | 2023-12-31 | 266.7 K | Mondrian Investment Partners Ltd | 2023-12-31 | 219 K | Acadian Asset Management Llc | 2023-12-31 | 211.3 K | Fisher Asset Management, Llc | 2023-12-31 | 205.3 K | Ameriprise Financial Inc | 2023-12-31 | 198.2 K | Goldman Sachs Group Inc | 2023-12-31 | 3.7 M | Blackrock Inc | 2023-12-31 | 3 M |
Dr Reddys Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Dr Reddys or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Dr Reddys' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a RDY stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.08 | |
β | Beta against NYSE Composite | 0.02 | |
σ | Overall volatility | 1.09 | |
Ir | Information ratio | 0 |
Dr Reddys Volatility Alert
Dr Reddys Laboratories has relatively low volatility with skewness of 0.18 and kurtosis of 1.85. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Dr Reddys' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Dr Reddys' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Dr Reddys Fundamentals Vs Peers
Comparing Dr Reddys' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Dr Reddys' direct or indirect competition across all of the common fundamentals between Dr Reddys and the related equities. This way, we can detect undervalued stocks with similar characteristics as Dr Reddys or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Dr Reddys' fundamental indicators could also be used in its relative valuation, which is a method of valuing Dr Reddys by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Dr Reddys to competition |
| Fundamentals | Dr Reddys | Peer Average |
| Return On Equity | 0.21 | -0.31 |
| Return On Asset | 0.12 | -0.14 |
| Profit Margin | 0.19 % | (1.27) % |
| Operating Margin | 0.25 % | (5.51) % |
| Current Valuation | (40.69 B) | 16.62 B |
| Shares Outstanding | 166.53 M | 571.82 M |
| Shares Owned By Institutions | 15.02 % | 39.21 % |
| Number Of Shares Shorted | 625.76 K | 4.71 M |
| Price To Earning | 31.58 X | 28.72 X |
| Price To Book | 3.70 X | 9.51 X |
| Price To Sales | 0.04 X | 11.42 X |
| Revenue | 245.88 B | 9.43 B |
| Gross Profit | 113.84 B | 27.38 B |
| EBITDA | 108.78 B | 3.9 B |
| Net Income | 60.48 B | 570.98 M |
| Cash And Equivalents | 2.93 B | 2.7 B |
| Cash Per Share | 208.58 X | 5.01 X |
| Total Debt | 13.47 B | 5.32 B |
| Debt To Equity | 0.12 % | 48.70 % |
| Current Ratio | 1.98 X | 2.16 X |
| Book Value Per Share | 1,609 X | 1.93 K |
| Cash Flow From Operations | 58.87 B | 971.22 M |
| Short Ratio | 3.51 X | 4.00 X |
| Earnings Per Share | 3.75 X | 3.12 X |
| Price To Earnings To Growth | 4.71 X | 4.89 X |
| Target Price | 79.92 | |
| Number Of Employees | 25.86 K | 18.84 K |
| Beta | 0.34 | -0.15 |
| Market Capitalization | 12.01 B | 19.03 B |
| Total Asset | 322.85 B | 29.47 B |
| Retained Earnings | 215.59 B | 9.33 B |
| Working Capital | 118.53 B | 1.48 B |
| Current Asset | 1.81 B | 9.34 B |
Dr Reddys Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as RDY . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1065.28 | |||
| Daily Balance Of Power | (1.14) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 71.71 | |||
| Day Typical Price | 71.64 | |||
| Price Action Indicator | (0.55) | |||
| Period Momentum Indicator | (0.66) | |||
| Relative Strength Index | 50.54 |
About Dr Reddys Buy or Sell Advice
When is the right time to buy or sell Dr Reddys Laboratories? Buying financial instruments such as RDY Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Dr Reddys in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 59 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Dr Reddys Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for RDY Stock analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.103 | Dividend Share 40 | Earnings Share 3.75 | Revenue Per Share 272.4618 | Quarterly Revenue Growth 0.066 |
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.